tradingkey.logo
tradingkey.logo
Pesquisar

Kestra Medical Technologies Ltd

KMTS
Adicionar à lista de desejos
26.720USD
+0.440+1.67%
Horário de mercado ETCotações atrasadas em 15 min
1.56BValor de mercado
PerdaP/L TTM

Mais detalhes de Kestra Medical Technologies Ltd Empresa

Kestra Medical Technologies, Ltd. is a commercial-stage, wearable medical device and digital healthcare company focused on transforming patient outcomes in cardiovascular disease using monitoring and therapeutic intervention technologies that are intelligent and connected. The Company has developed and is commercializing its Cardiac Recovery System platform, a comprehensive and advanced system that integrates monitoring, therapeutic treatment, digital health, and patient support services into a single, unified solution. The Company's Cardiac Recovery System platform includes ASSURE WCD, which is a wearable cardioverter defibrillator (WCD) used to protect patients at an elevated risk of sudden cardiac arrest (SCA). Its Cardiac Recovery System platform also includes fully integrated digital solutions and services such as the ASSURE patient application, Kestra CareStation remote patient data platform, Heart Alert Services, and ASSURE Assist services and ASSURE wearable ECG.

Informações de Kestra Medical Technologies Ltd

Código da empresaKMTS
Nome da EmpresaKestra Medical Technologies Ltd
Data de listagemMar 06, 2025
CEOWebster (Brian Daniel)
Número de funcionários330
Tipo de títulosOrdinary Share
Fim do ano fiscalMar 06
Endereço3933 Lake Washington Blvd Ne
CidadeKIRKLAND
Bolsa de valoresNASDAQ OMX - NASDAQ BASIC
PaísUnited States of America
Código postal98033
Telefone14252798002
Site
Código da empresaKMTS
Data de listagemMar 06, 2025
CEOWebster (Brian Daniel)

Executivos da empresa Kestra Medical Technologies Ltd

Nome
Nome/Posição
Posição
Ações detidas
Variação
Mr. Brian Webster
Mr. Brian Webster
President, Chief Executive Officer, Founder, Director
President, Chief Executive Officer, Founder, Director
280.02K
+21.67%
Ms. Traci S. Umberger
Ms. Traci S. Umberger
Chief Administrative Officer, General Counsel, Director
Chief Administrative Officer, General Counsel, Director
119.65K
+21.08%
Mr. Vaseem Mahboob
Mr. Vaseem Mahboob
Chief Financial Officer
Chief Financial Officer
40.06K
+62.97%
Dr. Elizabeth Kwo, M.D.
Dr. Elizabeth Kwo, M.D.
Independent Director
Independent Director
21.82K
--
Mr. Conor Hanley
Mr. Conor Hanley
Independent Director
Independent Director
13.12K
--
Ms. Debra Schotz
Ms. Debra Schotz
Senior Vice President - Marketing
Senior Vice President - Marketing
--
--
Mr. Al Ford
Mr. Al Ford
Chief Commercial Officer
Chief Commercial Officer
--
--
Mr. Jeffrey Schwartz
Mr. Jeffrey Schwartz
Independent Chairman of the Board
Independent Chairman of the Board
--
--
Mr. Toby AuWerter
Mr. Toby AuWerter
Independent Director
Independent Director
--
--
Mr. Maxwell Bikoff
Mr. Maxwell Bikoff
Independent Director
Independent Director
--
--
Ver Mais
Nome
Nome/Posição
Posição
Ações detidas
Variação
Mr. Brian Webster
Mr. Brian Webster
President, Chief Executive Officer, Founder, Director
President, Chief Executive Officer, Founder, Director
280.02K
+21.67%
Ms. Traci S. Umberger
Ms. Traci S. Umberger
Chief Administrative Officer, General Counsel, Director
Chief Administrative Officer, General Counsel, Director
119.65K
+21.08%
Mr. Vaseem Mahboob
Mr. Vaseem Mahboob
Chief Financial Officer
Chief Financial Officer
40.06K
+62.97%
Dr. Elizabeth Kwo, M.D.
Dr. Elizabeth Kwo, M.D.
Independent Director
Independent Director
21.82K
--
Mr. Conor Hanley
Mr. Conor Hanley
Independent Director
Independent Director
13.12K
--
Ms. Debra Schotz
Ms. Debra Schotz
Senior Vice President - Marketing
Senior Vice President - Marketing
--
--

Perguntas frequentes

Quem são os cinco principais acionistas de Kestra Medical Technologies Ltd?

Os cinco principais acionistas de Kestra Medical Technologies Ltd são: Mr. Brian Webster

Quantas instituições possuem ações da Kestra Medical Technologies Ltd (KMTS)?

Em 2026Q1, 218 instituições possuíam ações da Kestra Medical Technologies Ltd, com valor de mercado aproximado de 60.76M, representando 104.08% do total de ações. Em comparação com 2025Q4, a participação institucional aumentou em 5705735.00.